Deferred Tax Assets, Net of Valuation Allowance of Merck & Co., Inc. from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
Merck & Co., Inc. quarterly Deferred Tax Assets, Net of Valuation Allowance in USD history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • Merck & Co., Inc. Deferred Tax Assets, Net of Valuation Allowance for the quarter ending 31 Dec 2025 was $6,733,000,000, a 28% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Net of Valuation Allowance, YoY Quarterly Change (%)

Merck & Co., Inc. Quarterly Deferred Tax Assets, Net of Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $6,733,000,000 +$1,463,000,000 +28% 31 Dec 2025 10-K 24 Feb 2026 2025 FY
Q4 2024 $5,270,000,000 +$1,215,000,000 +30% 31 Dec 2024 10-K 24 Feb 2026 2025 FY
Q4 2023 $4,055,000,000 +$1,040,000,000 +34% 31 Dec 2023 10-K 25 Feb 2025 2024 FY
Q4 2022 $3,015,000,000 +$745,000,000 +33% 31 Dec 2022 10-K 26 Feb 2024 2023 FY
Q4 2021 $2,270,000,000 -$163,000,000 -6.7% 31 Dec 2021 10-K 24 Feb 2023 2022 FY
Q4 2020 $2,433,000,000 +$182,000,000 +8.1% 31 Dec 2020 10-K 25 Feb 2022 2021 FY
Q4 2019 $2,251,000,000 +$481,000,000 +27% 31 Dec 2019 10-K 25 Feb 2021 2020 FY
Q4 2018 $1,770,000,000 -$225,000,000 -11% 31 Dec 2018 10-K 26 Feb 2020 2019 FY
Q4 2017 $1,995,000,000 -$1,114,000,000 -36% 31 Dec 2017 10-K 27 Feb 2019 2018 FY
Q4 2016 $3,109,000,000 +$157,000,000 +5.3% 31 Dec 2016 10-K 27 Feb 2018 2017 FY
Q4 2015 $2,952,000,000 -$568,000,000 -16% 31 Dec 2015 10-K 28 Feb 2017 2016 FY
Q4 2014 $3,520,000,000 +$462,000,000 +15% 31 Dec 2014 10-K 26 Feb 2016 2015 FY
Q4 2013 $3,058,000,000 -$1,818,000,000 -37% 31 Dec 2013 10-K 27 Feb 2015 2014 FY
Q4 2012 $4,876,000,000 -$651,000,000 -12% 31 Dec 2012 10-K 27 Feb 2014 2013 FY
Q4 2011 $5,527,000,000 +$194,000,000 +3.6% 31 Dec 2011 10-K 28 Feb 2013 2012 FY
Q4 2010 $5,333,000,000 31 Dec 2010 10-K 28 Feb 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.